|Articles|February 1, 2011
- Pharmaceutical Executive-02-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2011
The Promise Of Translational Medicine
Advertisement
Articles in this issue
over 15 years ago
Skipping the Needle: Pharm Exec's Brand of the Yearover 15 years ago
Honing Reforms from Clinical Developmentover 15 years ago
Growing Stronger After the StormAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5